.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Julphar
Johnson and Johnson
McKesson
Boehringer Ingelheim
Teva
Chubb
Express Scripts
Covington
Argus Health

Generated: July 25, 2017

DrugPatentWatch Database Preview

QUESTRAN Drug Profile

« Back to Dashboard

What is the patent landscape for Questran, and when can generic versions of Questran launch?

Questran is a drug marketed by Apothecon and Bristol Myers and is included in three NDAs.

The generic ingredient in QUESTRAN is cholestyramine. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.

Summary for Tradename: QUESTRAN

Patents:0
Applicants:2
NDAs:3
Clinical Trials: see list3
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:QUESTRAN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
QUESTRAN
cholestyramine
TABLET;ORAL073403-001Apr 28, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers
QUESTRAN
cholestyramine
POWDER;ORAL016640-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Apothecon
QUESTRAN
cholestyramine
TABLET;ORAL073403-002Dec 27, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers
QUESTRAN
cholestyramine
POWDER;ORAL016640-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Bristol Myers
QUESTRAN LIGHT
cholestyramine
POWDER;ORAL019669-003Dec 5, 1988DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Teva
Argus Health
Merck
Citi
Mallinckrodt
Farmers Insurance
Fuji
Novartis
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot